Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.071
https://www.valueinhealthjournal.com/article/S1098-3015(17)30405-9/fulltext
Title :
Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30405-9&doi=10.1016/j.jval.2017.08.071
First page :
A409
Section Title :
BREAKOUT SESSION XIV
Open access? :
No
Section Order :
54